FGP
XYL icon

Freestone Grove Partners’s Xylem XYL Stock Holding History

Freestone Grove Partners’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,136
Closed -$1.69M – 1366
2026
Q1 		$1.69M Sell
14,136
-153,219
-92% -$20.1M 0.01% 395
2025
Q4 		$22.8M Sell
167,355
-20,547
-11% -$2.96M 0.16% 186
2025
Q3 		$27.7M Buy
187,902
+175,345
+1,396% +$24.3M 0.21% 164
2025
Q2 		$1.62M Sell
12,557
-164,495
-93% -$19.9M 0.01% 389
2025
Q1 		$21.2M Buy
+177,052
New +$21.9M 0.22% 158

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Freestone Grove Partners's XYL Position: Q2 2026 in Review

Freestone Grove Partners sold out of Xylem (XYL) in Q2 2026, closing a stake of 14,136 shares — an estimated $1.69M sold.

Freestone Grove Partners first reported a position in XYL in Q1 2025 and held it in 5 quarters. The position peaked at $27.7M in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Freestone Grove Partners reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 14,136 Xylem shares in Q2 2026, an estimated $1.69M.
  • Freestone Grove Partners first reported a position in Xylem in Q1 2025 and held it in 5 quarters.
  • Freestone Grove Partners's Xylem position peaked at $27.7M in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.